By Yustina Yustina

Moisturizers, sunscreens, and anti-aging creams have long been marketed on well-established promises: locking moisture into the skin, reinforcing its protective barrier, shielding against UV damage, and minimizing visible signs of aging. These core functions remain essential to maintaining skin health.

Increasingly, however, researchers are adopting a wider lens. The skin is not merely a passive barrier — it functions as an active immune organ whose cells identify potential threats, transmit signals, and coordinate tissue repair. It also hosts diverse microbial communities that interact with both the skin barrier and the immune system.

This evolving understanding could reshape how skincare products are formulated, how companies evaluate them, and what claims regulators ultimately permit. For a global skincare market valued at well over $100 billion, the commercial implications of even incremental formulation breakthroughs are substantial.

The Skin as an Immune Organ

Skin cells can detect pathogens, pollutants, and injury signals. In response, they release signaling proteins that help orchestrate inflammation and healing. A broader network of immune cells identifies potentially harmful substances, removes damaged cells, and helps ensure that immune reactions do not persist longer than necessary.

Inflammation plays a vital role when skin is injured or infected. Yet immune responses that are excessive or poorly regulated can drive irritation and disease.

Research into acne, for example, suggests that inflammation may begin before blemishes become visible. While excess sebum production, clogged hair follicles, and Cutibacterium acnes bacteria remain key factors, immune responses also significantly shape how acne develops. Acne is among the most prevalent skin conditions worldwide, affecting an estimated 9.4% of the global population across age groups.

Rosacea involves inflammation accompanied by changes in skin nerves and blood vessels. Atopic dermatitis — commonly referred to as atopic eczema — arises from a combination of a compromised skin barrier and dysregulated immune responses and affects an estimated 15–20% of children globally. Psoriasis is classified as an immune-mediated inflammatory disease, and contact dermatitis results from exposure to an irritant or allergen.

Though these conditions have distinct causes, together they illustrate why skin problems cannot always be understood by examining only the surface. Immune signals interact with the skin barrier, nerves, blood vessels, and resident microbes in complex ways.

Inflammation and Aging

Inflammation may also influence how skin ages. Scientists use the term "inflammaging" to describe the chronic, low-grade inflammation associated with aging. Research indicates that this process may impair tissue repair and contribute to changes in collagen and other structural components that support the skin.

Researchers are therefore investigating whether skincare products could reduce harmful inflammation while also protecting against sun-related skin aging. However, evidence that cosmetic products can meaningfully slow inflammaging in humans remains limited.

The Skin Microbiome

The skin microbiome represents another rapidly expanding field of study. It encompasses the bacteria, fungi, and other microscopic organisms residing on the skin. These communities differ from person to person and across various regions of the body. The field has advanced partly in parallel with gut microbiome research, which has already influenced food and supplement markets and provided methodological templates for studying microbial communities on other body surfaces.

Microbes can engage with immune cells and contribute to defense against pathogens. They can also influence inflammation and skin-barrier function. Researchers have not yet established a definitive description of what constitutes a healthy skin microbiome, nor have they determined whether permanent alterations to it are universally beneficial.

That uncertainty has not dampened industry enthusiasm. Claims about "balancing," "supporting," or "protecting" the skin microbiome now feature prominently in microbiome-focused skincare lines.

Some products incorporate probiotics, prebiotics, or postbiotics. Probiotics contain live microorganisms. Prebiotics are compounds designed to nourish specific microorganisms. Postbiotics consist of inactivated microorganisms or their components.

Research on their dermatological applications has yielded some promising findings, though the specific products, organisms, and methodologies examined vary considerably. Published reviews of probiotics and postbiotics in skincare consistently conclude that larger, more rigorously designed clinical trials are still needed.

Rethinking Product Testing

Emerging research may also transform how skincare products are evaluated. Cosmetic studies already rely on metrics such as hydration, transepidermal water loss, and visible wrinkle depth. Future trials could incorporate biological markers, including cytokines — the proteins cells use to communicate immune signals.

Scientists can already measure certain inflammatory cytokines in skin samples. A measurable shift in a laboratory value, however, does not automatically translate into a perceptible or clinically meaningful benefit. Establishing that link would require dedicated trials.

Nanotechnology may offer new methods for delivering cosmetic ingredients. Nanoparticles are minuscule particles whose size, shape, and surface characteristics can govern how they interact with cells. Researchers are exploring whether they could transport active ingredients while simultaneously modulating immune responses.

This work remains experimental. Whether nanoparticle-based systems can reliably regulate inflammation or enhance skin repair in humans has yet to be demonstrated.

Regulatory Boundaries

Claims involving immune function may also challenge the legal distinction between cosmetics and medicines. The UK's Medicines and Healthcare products Regulatory Agency evaluates a product's claims, intended use, and biological mechanism when determining whether it should be regulated as a medicine. In the United States, the Food and Drug Administration applies a similar framework: products intended to cleanse or beautify are classified as cosmetics, while those claiming to treat or prevent disease — or that affect the body's structure or function — fall under the drug category with correspondingly higher evidence requirements.

A cream marketed to cleanse, protect, or improve the appearance of skin may be classified as a cosmetic. A product presented as treating disease or altering immune function through an immunological mechanism, however, may fall under the definition of a medicine — subjecting it to more stringent evidence and regulatory requirements.

Skin immunity stands to become a significant frontier in cosmetic science. The research points toward credible new frameworks for understanding skin health, but commercial claims are likely to outpace clinical evidence.

Consumers and regulators alike will need to differentiate between products that have been demonstrated to deliver tangible benefits and those that simply appropriate the vocabulary of an emerging scientific field.

— The Conversation via Reuters Connect

Yustina Yustina is a PhD Candidate in Cancer and Pharmaceutical Sciences at King's College London. She is affiliated with the Indonesian Food and Drug Authority.